27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Shares of Gilead Sciences (NASDAQ:GILD) decreased in after-market trading after the company reported Q1 results.
Quarterly Results
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Earnings per share were up 23.81% year over year to $2.08, which missed the estimate of $2.09.
Revenue of $6,423,000,000 higher by 15.77% year over year, which missed the estimate of $6,740,000,000.
Outlook
The upcoming fiscal year's EPS expected to be between $6.75 and $7.45.
The upcoming fiscal year's revenue expected to be between $21,700,000,000 and $22,100,000,000.
Details Of The Call
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Date: Apr 29, 2021
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/4j7y6i4m
Technicals
Company's 52-week high was at $85.67
52-week low: $56.56
Price action over last quarter: down 8.98%
Company Description
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.